microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma

Increasing evidence suggests that microRNAs’ (miRNAs) abnormal expression is one of the main factors of chemotherapy resistance in various cancers. However, the role of miRNAs in lung adenocarcinoma (LUAD) resistance to cisplatin is still unclear. In this study, we analyzed a microarray dataset to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziyao, Zhou, Lingxuan, Chen, Bisong, Li, Xu, Zou, Qiuyi, Xu, Wei, Fang, Li, Wu, Anbang, Li, Zheng, Chen, Yuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137726/
https://www.ncbi.nlm.nih.gov/pubmed/37107669
http://dx.doi.org/10.3390/genes14040911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137726/
https://www.ncbi.nlm.nih.gov/pubmed/37107669
http://dx.doi.org/10.3390/genes14040911

Ejemplares similares